Bioscience Technology

Pulse Biosciences’ nPulse™ Technology to be Featured at the 21st Annual International VT Symposium 2026

Pulse Biosciences, Inc. (Nasdaq: PLSE), the company leveraging its ever evolving novel and proprietary Nanosecond Pulsed ...

Appearing as a "biotech company that synthesizes DNA," it has actually solidified its position as the "data infrastructure" for the era of AI-driven drug discovery ...

In September 2026, the stock price of Twist Bioscience (Nasdaq: TWST) rose 16% in a single day, reaching $184. The catalyst ...

BioSpace

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - October 9, 2026

(Nasdaq: PLSE), the company leveraging its ever evolving novel and proprietary Nanosecond Pulsed Field Ablation™ (nano-PFA or ...

Yahoo Finance

Atrandi Biosciences Raises $25M Series A Led by Lux Capital to Drive the Future of Single-Cell Multiomics with Semi-Permeable Capsule Technology

Atrandi Biosciences' Semi-Permeable Capsule (SPC) technology in action: SPCs selectively retain cells and nucleic acids while allowing small molecules to flow through. Atrandi Biosciences founders, ...

Business Wire

Pulse Biosciences’ Nanosecond PFA Technology to be Featured in Multiple Presentations at the AF Symposium

MIAMI--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nsPFA™) technology, today announced that its nsPFA ...

Hosted on MSN

How Colossal Bioscience's de-extinction technology works

Researchers at Dallas-based Colossal Biosciences rely on ancient DNA from extinct species and the genome of their closest living relatives to determine how they can be brought back. Why it matters: ...

BioSpectrum India on MSN

Governor Gianforte, Karnataka minister of information technology discuss partnerships in bioscience

The leaders discussed opportunities to connect Montana’s research institutions, clinics, and bioscience companies with ...

Business Insider

Lancet Neurology Study Using Alamar Biosciences’ Technology Reveals Divergent Biological Responses to Alzheimer’s Treatment

FREMONT, Calif., Sept. 24, 2026 (GLOBE NEWSWIRE) -- Alamar Biosciences, Inc. (Nasdaq: ALMR), a leader in precision proteomics dedicated to enabling the earliest detection of disease, today announced ...